Australia – NSW: MP pushes back against regulators’ ‘punitive’ approach towards medicinal cannabis prescribers | Cannabis Law Report | How to order Skittles Moonrock online

Learn where to order CBD Vape online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

Cannabiz Australia

Legalise Cannabis New South Wales MP Jeremy Buckingham has told the Upper House he will introduce a motion urging regulators to reconsider their “punitive” approach towards medicinal cannabis prescribers.

In a notice of motion that passed last night (October 16), Buckingham said that on the next sitting day he will call for the House to recognise that “an increasing number of medical practitioners in New South Wales are being reprimanded, investigated, or punished by the Therapeutic Good Administration (TGA) and the Medical Practitioners Board for prescribing medicinal cannabis in accordance with patient needs and established medical guidelines”.

The motion will urge the House to acknowledge the “growing body of evidence supporting the therapeutic benefits of medicinal cannabis in treating a range of conditions, including chronic pain, epilepsy, cancer-related symptoms and mental health disorders, and the growing acceptance of its use both in Australia and internationally”.

Buckingham will also ask fellow MPs to back a call for the TGA and the Medical Practitioners Board to “reconsider their punitive approach toward medical professionals prescribing cannabis” and to adopt a framework that “encourages responsible prescribing, promotes patient access, and supports the well-being of individuals who benefit from medicinal cannabis”.

The motion will go on to encourage “meaningful dialogue with medical professionals, patients, and advocacy groups to ensure that doctors prescribing medicinal cannabis are protected from undue scrutiny… in their clinical decision-making, provided they act in good faith and within established clinical guidelines”.

In a further call, Buckingham will press the need to “provide greater clarity and transparency in the regulatory environment surrounding medicinal cannabis in New South Wales, including reforms that would protect practitioners from regulatory overreach, encourage research, and facilitate better patient access to this crucial medicine”.

Read the full report